Table 1.

Clinical and demographic characteristics of the HF patients at time of listing for cardiac transplantation

Number of patients	18
Age, years	46.4±12.1
Male gender, n (%)	12 (66.7)
Caucasian ethnicity, n (%)	12 (67.7)
Ischemic etiology of HF, n (%)	5 (27.8)
Diabetes mellitus, n (%)	2(11.1)
Hypertension, n (%)	3 (16.7)
Cerebrovascular disease, n (%)	4(22.2)
Permanent atrial fibrillation, n (%)	4(22.2)
Cardiac output, 1/min	3.52±1.40
Right atrial pressure, cm H2O	9.67±7.18
Pulmonary artery wedge pressure, mm Hg	19.17±7.75
Left ventricular ejection fraction, %	20.7±13.8
Left ventricular end-diastolic dimension, cm	7.37±1.81
Hemoglobin, mg/dl	13.44±2.23
ACE/ARB inhibitors, n (%)	15(83.3)
Beta-blockers, n (%)	13 (72.2)
Digoxin, n (%)	16 (88.9)
Hydralazine, n (%)	8 (44.4)
Nitrates, n (%)	10 (55.6)
Statins, n (%)	6(33.3)